The Trump administration’s travel ban will remain on a temporary hold under an order issued today by a federal appeals court in San Francisco, which held that the government had failed to make its case for lifting a stay won through... Read more »
Since Xconomy’s founding nearly a decade ago, we have grown from a single bureau in Boston to having editors covering 11 innovation clusters around the United States. And over this time, we have cultivated a reputation for outstanding news coverage and... Read more »
In August 2015, Spredfast, an Austin, TX-based developer of social media management software, acquired Madison, WI-based Shoutlet for an undisclosed sum. In a message announcing the deal, Spredfast said that the staff and headquarters of Shoutlet—which sold cloud-based software to... Read more »
Propeller Health, a Madison, WI-based startup that makes Internet-connected inhalers and sensors designed to help asthma and chronic obstructive pulmonary disease (COPD) patients, says it is teaming up with Novartis to build an add-on sensor for the Swiss pharma giant’s... Read more »
When disease decimated Ireland’s potatoes in 1845, farmers were at a loss to explain what caused their staple crop to rot in the fields. The blight continued in successive growing seasons and by 1851, more than one million deaths were attributed... Read more »
Scaling a mountain, even a figurative one, sometimes requires making changes on the fly.
Catalyze, an early-stage healthtech company based in Madison, WI, previously used a mountaineering theme when choosing names for its primary software applications. It chose the climbing term... Read more »
The blowback from U.S. business leaders to President Trump’s travel ban continues—today from a throng of biotech executives. This morning, 165 U.S. biotech leaders have signed a letter voicing “deep concern and opposition” to the order, which bars entry to the... Read more »
Get caught up to speed on news from Wisconsin’s innovation community with these recent headlines:
—Madison-based Exact Sciences (NASDAQ: EXAS) said that Cologuard, the company’s stool-based DNA test for colorectal cancer, is slated to be included in the Centers for... Read more »
President Trump’s order to bar refugees and immigrants from seven Muslim-majority countries is on temporary hold, and a court hearing later today could eventually force a ruling by the U.S. Supreme Court.
One of the latest biotech executives to speak out... Read more »